Vital Signs - Pharmaceutical & Biotechnology Outsourcing - Growth Opportunities, Trends & Strategies

Vital Signs - Pharmaceutical & Biotechnology Outsourcing - Growth Opportunities, Trends & Strategies

 

RELEASE DATE
18-May-2009
REGION
North America
Deliverable Type
Market Research
Research Code: 9561-00-8D-00-00
SKU: HC00570-NA-MR_04043
AvailableYesPDF Download

$1,500.00

Special Price $1,125.00 save 25 %

In stock
SKU
HC00570-NA-MR_04043

$1,500.00

$1,125.00save 25 %

DownloadLink
ENQUIRE NOW

Description

This issue of Vital Signs, released on May 18, 2009, provides a strategic overview of opportunities and issues in the pharmaceutical and biotechnology outsourcing services markets. Additionally, a company spotlight is provided for Aerie Pharmaceuticals, an emerging pharma company focused on glaucoma. Reimbursement and regulatory news from the FDA is also provided for the week of May 4, 2009.

Table of Contents

This week's issue:

This issue of Vital Signs, released on May 18, 2009, provides a strategic overview of opportunities and issues in the pharmaceutical and biotechnology outsourcing services markets. Additionally, a company spotlight is provided for Aerie Pharmaceuticals, an emerging pharma company focused on glaucoma. Reimbursement and regulatory news from the FDA is also provided for the week of May 4, 2009.
More Information
Deliverable Type Market Research
No Index Yes
Podcast No
Industries Healthcare
WIP Number 9561-00-8D-00-00
Is Prebook No